Board Committee Changes

RNS Number : 7403F
Reckitt Benckiser Group PLC
29 July 2016
 

29 July 2016

RECKITT BENCKISER GROUP PLC

(The "Company" or "RB")

 

BOARD COMMITTEE CHANGES

 

The Company is pleased to announce the following changes to its standing Board Committees and their membership.

New Corporate Responsibility, Sustainability, Ethics and Compliance Committee

On the recommendation of the Nomination Committee, on 28 July 2016 the Board approved the establishment of a new Board committee to be known as the Corporate Responsibility, Sustainability, Ethics and Compliance Committee ("CRSEC Committee") with immediate effect.  This new committee will support the Board in fulfilling its duty to safeguard and advance the Company's reputation for responsible and sustainable corporate conduct by reviewing, monitoring and assessing its approach to and management of corporate social responsibility, environmental and sustainability issues and behaviours, ethical conduct and regulatory compliance.  

The CRSEC Committee will be chaired by Pam Kirby, and Adrian Bellamy and Nicandro Durante have been appointed as committee members.  The CRSEC Committee will meet at least three times per year and at such other times as required. 

The Committee's terms of reference will be available on the Company's website at www.rb.com

Nomination Committee Membership

The Nomination Committee also recommended, and the Board approved, the appointment of Pam Kirby to the Nomination Committee with immediate effect. 

This disclosure is made in accordance with paragraph 9.6.11 of the Financial Conduct Authority's Listing rules.

 

For further Information:

Chris Logan
Company Secretary
+44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations, Communications & External Affairs

+44 (0)1753 217 800

 

 

About RB:

 

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

 

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

 


For more information visit www.rb.com

 

*RB is the trading name of the Reckitt Benckiser group of companies

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEEFIUFMSELW
UK 100

Latest directors dealings